PubMed:17166870 / 1086-1377 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T13","span":{"begin":0,"end":291},"obj":"Sentence"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-entities","denotations":[{"id":"3716","span":{"begin":45,"end":50},"obj":"SequenceVariant"},{"id":"3717","span":{"begin":61,"end":64},"obj":"DiseaseOrPhenotypicFeature"},{"id":"3718","span":{"begin":65,"end":73},"obj":"OrganismTaxon"},{"id":"3719","span":{"begin":90,"end":93},"obj":"DiseaseOrPhenotypicFeature"},{"id":"3720","span":{"begin":237,"end":240},"obj":"DiseaseOrPhenotypicFeature"},{"id":"3721","span":{"begin":241,"end":249},"obj":"OrganismTaxon"},{"id":"3722","span":{"begin":258,"end":261},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A24","pred":"db_id","subj":"3716","obj":"c|INS||6"},{"id":"A25","pred":"db_id","subj":"3717","obj":"MESH:D012595"},{"id":"A26","pred":"db_id","subj":"3718","obj":"NCBITaxon:9606"},{"id":"A27","pred":"db_id","subj":"3719","obj":"MESH:D000081029"},{"id":"A28","pred":"db_id","subj":"3720","obj":"MESH:D012595"},{"id":"A29","pred":"db_id","subj":"3721","obj":"NCBITaxon:9606"},{"id":"A30","pred":"db_id","subj":"3722","obj":"MESH:D000081029"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-SeqVar","denotations":[{"id":"T3","span":{"begin":45,"end":50},"obj":"SequenceVariant"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T12","span":{"begin":32,"end":41},"obj":"GeneOrGeneProduct"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T20","span":{"begin":32,"end":41},"obj":"GeneOrGeneProduct"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T11","span":{"begin":61,"end":64},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":90,"end":93},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T13","span":{"begin":237,"end":240},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T14","span":{"begin":258,"end":261},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A11","pred":"originalLabel","subj":"T11","obj":"D012595"},{"id":"A12","pred":"originalLabel","subj":"T12","obj":"D000081029"},{"id":"A13","pred":"originalLabel","subj":"T13","obj":"D012595"},{"id":"A14","pred":"originalLabel","subj":"T14","obj":"D000081029"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T16","span":{"begin":61,"end":64},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T17","span":{"begin":90,"end":93},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T19","span":{"begin":237,"end":240},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T20","span":{"begin":258,"end":261},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"0005100"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"0015924"},{"id":"A18","pred":"mondo_id","subj":"T17","obj":"0024533"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"0005100"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"0015924"},{"id":"A21","pred":"mondo_id","subj":"T20","obj":"0024533"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T13","span":{"begin":61,"end":64},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T14","span":{"begin":90,"end":93},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T15","span":{"begin":237,"end":240},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T16","span":{"begin":258,"end":261},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A13","pred":"ID:","subj":"T13","obj":"D012595"},{"id":"A14","pred":"ID:","subj":"T14","obj":"D000081029"},{"id":"A15","pred":"ID:","subj":"T15","obj":"D012595"},{"id":"A16","pred":"ID:","subj":"T16","obj":"D000081029"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T13","span":{"begin":61,"end":64},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T14","span":{"begin":90,"end":93},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T15","span":{"begin":237,"end":240},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T16","span":{"begin":258,"end":261},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A13","pred":"#label","subj":"T13","obj":"D012595"},{"id":"A14","pred":"#label","subj":"T14","obj":"D000081029"},{"id":"A15","pred":"#label","subj":"T15","obj":"D012595"},{"id":"A16","pred":"#label","subj":"T16","obj":"D000081029"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T9","span":{"begin":90,"end":93},"obj":"ChemicalEntity"},{"id":"T13","span":{"begin":258,"end":261},"obj":"ChemicalEntity"}],"attributes":[{"id":"A9","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_53305"},{"id":"A10","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_33848"},{"id":"A11","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_31204"},{"id":"A12","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_104011"},{"id":"A13","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_53305"},{"id":"A14","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_33848"},{"id":"A15","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_31204"},{"id":"A16","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_104011"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T2","span":{"begin":65,"end":73},"obj":"OrganismTaxon"},{"id":"T3","span":{"begin":241,"end":249},"obj":"OrganismTaxon"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"LitCoin-training-merged","denotations":[{"id":"T13","span":{"begin":258,"end":261},"obj":"ChemicalEntity"},{"id":"T9","span":{"begin":90,"end":93},"obj":"ChemicalEntity"},{"id":"T16","span":{"begin":258,"end":261},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T15","span":{"begin":237,"end":240},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T14","span":{"begin":90,"end":93},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T33282","span":{"begin":61,"end":64},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T93461","span":{"begin":241,"end":249},"obj":"OrganismTaxon"},{"id":"T57119","span":{"begin":65,"end":73},"obj":"OrganismTaxon"},{"id":"T37731","span":{"begin":45,"end":50},"obj":"SequenceVariant"}],"attributes":[{"id":"A16","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_104011"},{"id":"A15","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_31204"},{"id":"A14","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_33848"},{"id":"A13","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_53305"},{"id":"A12","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_104011"},{"id":"A11","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_31204"},{"id":"A10","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_33848"},{"id":"A9","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_53305"},{"id":"A73725","pred":"#label","subj":"T16","obj":"D000081029"},{"id":"A25192","pred":"#label","subj":"T15","obj":"D012595"},{"id":"A8191","pred":"#label","subj":"T14","obj":"D000081029"},{"id":"A39585","pred":"#label","subj":"T33282","obj":"D012595"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}

{"project":"tmVarCorpus","denotations":[{"id":"T3","span":{"begin":45,"end":50},"obj":"DNAMutation:|INS||6"}],"text":"We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:"}